Pharm-Olam is a midsized CRO with 20+ years of experience committed to ease of collaboration and delivery. Agile, innovative, and flexible full-service solutions make us the chosen partner for small to midsize biopharma involved in rare disease clinical research.
For more than 20 years, we have specialized in rare and orphan disease research supporting over 120+ clinical trials including 16 product approvals, across a variety of novel therapy classes and precision medicine including; gene therapies, GMO’s, stem cell therapies, and mRNA and antisense therapies.
Download Now
